CODX Co-Diagnostics Inc

Price (delayed)

$1.35

Market cap

$42.23M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.32

Enterprise value

$21.92M

Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets a state-of-the-art diagnostics technology. The Company's technology is utilized for tests that are designed using ...

Highlights
The company's debt has surged by 198% YoY but it fell by 7% QoQ
The company's gross profit has shrunk by 71% YoY but it rose by 5% QoQ
Co-Diagnostics's quick ratio has shrunk by 56% YoY and by 7% QoQ
The revenue has contracted by 45% YoY

Key stats

What are the main financial stats of CODX
Market
Shares outstanding
31.28M
Market cap
$42.23M
Enterprise value
$21.92M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.54
Price to sales (P/S)
6.03
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.28
Earnings
Revenue
$6.68M
EBIT
-$39.38M
EBITDA
-$38.09M
Free cash flow
-$26.66M
Per share
EPS
-$1.32
Free cash flow per share
-$0.89
Book value per share
$2.51
Revenue per share
$0.22
TBVPS
$2.02
Balance sheet
Total assets
$86.67M
Total liabilities
$8.32M
Debt
$2.79M
Equity
$78.35M
Working capital
$48.43M
Liquidity
Debt to equity
0.04
Current ratio
10.19
Quick ratio
9.56
Net debt/EBITDA
0.53
Margins
EBITDA margin
-570.4%
Gross margin
41.3%
Net margin
-582.4%
Operating margin
-644.1%
Efficiency
Return on assets
-38.6%
Return on equity
-42.4%
Return on invested capital
-69.6%
Return on capital employed
-48.4%
Return on sales
-589.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CODX stock price

How has the Co-Diagnostics stock price performed over time
Intraday
3.85%
1 week
8%
1 month
-1.46%
1 year
8.87%
YTD
1.5%
QTD
8%

Financial performance

How have Co-Diagnostics's revenue and profit performed over time
Revenue
$6.68M
Gross profit
$2.76M
Operating income
-$43.01M
Net income
-$38.89M
Gross margin
41.3%
Net margin
-582.4%
The company's net margin has shrunk by 123% YoY and by 12% QoQ
The company's gross profit has shrunk by 71% YoY but it rose by 5% QoQ
Co-Diagnostics's operating margin has plunged by 67% YoY and by 2.7% from the previous quarter
Co-Diagnostics's gross margin has decreased by 47% YoY but it has increased by 7% QoQ

Growth

What is Co-Diagnostics's growth rate over time

Valuation

What is Co-Diagnostics stock price valuation
P/E
N/A
P/B
0.54
P/S
6.03
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.28
CODX's EPS is down by 31% year-on-year and by 10% since the previous quarter
The P/B is 85% below the 5-year quarterly average of 3.6 but 35% above the last 4 quarters average of 0.4
The equity has declined by 29% year-on-year and by 9% since the previous quarter
The P/S is 71% below the 5-year quarterly average of 20.9 but 10% above the last 4 quarters average of 5.5
The revenue has contracted by 45% YoY

Efficiency

How efficient is Co-Diagnostics business performance
CODX's return on sales has dropped by 79% year-on-year and by 5% since the previous quarter
CODX's return on equity has dropped by 69% year-on-year and by 20% since the previous quarter
The ROA has plunged by 67% YoY and by 18% from the previous quarter
CODX's return on invested capital is down by 25% since the previous quarter but it is up by 15% year-on-year

Dividends

What is CODX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CODX.

Financial health

How did Co-Diagnostics financials performed over time
The current ratio has plunged by 57% YoY and by 6% from the previous quarter
Co-Diagnostics's quick ratio has shrunk by 56% YoY and by 7% QoQ
The company's debt is 96% lower than its equity
The company's debt has surged by 198% YoY but it fell by 7% QoQ
The debt to equity is up by 33% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.